Pharmacoproteomic Study of the Natural Product Ebenfuran III in DU-145 Prostate Cancer Cells: The Quantitative and Temporal Interrogation of Chemically Induced Cell Death at the Protein Level

• Published in: Journal of proteome research 2013-04, Vol.12 (4), p.1591-1603
• Main Authors: Roumeliotis, Theodoros I, Halabalaki, Maria, Alexi, Xanthippi, Ankrett, Dyan, Giannopoulou, Eugenia G, Skaltsounis, Alexios-Leandros, Sayan, Berna S, Alexis, Michael N, Townsend, Paul A, Garbis, Spiros D
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents, Phytogenic - pharmacology; Apoptosis Regulatory Proteins - metabolism; Benzofurans - pharmacology; Calpain - metabolism; Cell Death - drug effects; Cell Line, Tumor; Chromatography, Reverse-Phase - methods; Cluster Analysis; Humans; Male; Membrane Proteins - metabolism; Mitogen-Activated Protein Kinase 1 - metabolism; Prostatic Neoplasms - drug therapy; Prostatic Neoplasms - metabolism; Prostatic Neoplasms - pathology; Proteins - analysis; Proteins - metabolism; rab GTP-Binding Proteins - metabolism; Resorcinols - pharmacology; Tandem Mass Spectrometry - methods
• ISSN: 1535-3893; 1535-3907
• DOI: 10.1021/pr300968q

A naturally occurring benzofuran derivative, Ebenfuran III (Eb III), was investigated for its antiproliferative effects using the DU-145 prostate cell line. Eb III was isolated from Onobrychis ebenoides of the Leguminosae family, a plant endemic in Central and Southern Greece. We have previously reported that Eb III exerts significant cytotoxic effects on certain cancer cell lines. This effect is thought to occur via the isoprenyl moiety at the C-5 position of the molecule. The study aim was to gain a deeper understanding of the pharmacological effect of Eb III on DU-145 cell death at the translational level using a relative quantitative and temporal proteomics approach. Proteins extracted from the cell pellets were subjected to solution phase trypsin proteolysis followed by iTRAQ-labeling. The labeled tryptic peptide extracts were then fractionated using strong cation exchange chromatography and the fractions were analyzed by nanoflow reverse phase ultraperformance liquid chromatography–nanoelectrospray ionization-tandem mass spectrometry analysis using a hybrid QqTOF platform. Using this approach, we compared the expression levels of 1360 proteins analyzed at ≤1% global protein false discovery rate (FDR), commonly present in untreated (control, vehicle only) and Eb III-treated cells at the different exposure time points. Through the iterative use of Ingenuity Pathway Analysis with hierarchical clustering of protein expression patterns, followed by bibliographic research, the temporal regulation of the Calpain-1, ERK2, PAR-4, RAB-7, and Bap31 proteins were identified as potential nodes of multipathway convergence to Eb III induced DU-145 cell death. These proteins were further verified with Western blot analysis. This gel-free, quantitative 2DLC–MS/MS proteomics method effectively captured novel modulated proteins in the DU-145 cell line as a response to Eb III treatment. This approach also provided greater insight to the multifocal and combinatorial signaling pathways implicated in Eb III-induced cell death.